The Chemotherapy Source BookMichael Clinton Perry The Chemotherapy Source Book, Fourth Edition pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any question encountered in the delivery of chemotherapy. This updated Fourth Edition includes new drugs as well as new indications for older drugs. Content has been streamlined to provide essential information more quickly for the busy practitioner. Plus, this edition is softcover for greater portability and convenience. |
Contents
SCIENTIFIC PRINCIPLES OF CHEMOTHERAPY | 1 |
NortonSimon Hypothesis | 7 |
Drug Resistance | 21 |
Principles of Chemotherapy | 30 |
Clinical Trials | 37 |
Hematopoietic Growth Factors | 44 |
Principles of Biotherapy | 53 |
ROUTES OF ADMINISTRATION | 65 |
DRUG ADMINISTRATION | 297 |
General Issues in Brain Tumor Chemotherapy | 311 |
Chemotherapy of Head and Neck Cancer | 324 |
Chemotherapy of Lung Cancer | 341 |
Breast Cancer | 363 |
Gastrointestinal Cancer | 408 |
Endocrine Tumors | 417 |
Chemotherapy of Genitourinary Cancers | 424 |
Intraperitoneal Chemotherapy | 75 |
Intraarterial Chemotherapy | 88 |
Isolated Regional Therapy | 99 |
Hematopoietic Stem Cell Transplantation | 108 |
MANAGEMENT OF DRUG TOXITY | 115 |
Dermatologic Toxicity | 136 |
Hypersensitivity Reactions | 152 |
Ocular Side Effects of Chemotherapy | 174 |
Pulmonary Toxicity of Antineoplastic Therapy | 191 |
Hepatotoxicity of Chemotherapeutic Agents | 209 |
Renal and Electrolyte Abnormalities Due to Chemotherapy | 223 |
Vascular Toxicity of Antineoplastic Agents | 245 |
Second Malignancies After Chemotherapy | 259 |
Chemotherapy in Pregnancy | 273 |
Chemotherapy of Gynecologic Cancers | 447 |
Chemotherapy of Carcinoma of Unknown Primary Site | 464 |
Chemotherapy of Bone and Soft Tissue Sarcomas | 476 |
Chemotherapy for Pediatric Solid Tumors | 492 |
Chemotherapy of Hodgkins Lymphoma | 499 |
NonHodgkins Lymphoma | 518 |
Acute Myeloid Leukemia Acute Lymphoblastic Leukemia and Chronic Lymphocytic | 534 |
Chemotherapy of the Myelodysplastic Syndromes | 552 |
Management of Myeloproliferative Disorders and Chronic Myeloid Leukemia | 560 |
Chemotherapy of Multiple Myeloma and Other Plasma Cell Disorders | 568 |
APPENDICES | 575 |
| 739 | |
Other editions - View all
The Chemotherapy Source Book Michael C. Perry,Jonathan W. Pine,Anne E. Jacobs No preview available - 2008 |
Common terms and phrases
5-fluorouracil activity acute adjuvant chemotherapy administration allogeneic Ann Intern antibody antitumor arterial associated autologous bevacizumab bleomycin Blood bone marrow transplantation breast cancer cancer patients Cancer Res Cancer Treat Rep carboplatin cardiac catheter cell lung cancer cetuximab chemotherapeutic agents chronic CIPN cisplatin Clin Oncol clinical trials colorectal cancer combination chemotherapy complications cycles cyclophosphamide cytarabine cytotoxic docetaxel dose doxorubicin drug effects Engl etoposide evaluation gemcitabine growth factor head and neck hepatic high-dose Hodgkin's disease HSRS increased induced infection infusion inhibitors interferon intravenous irinotecan leukemia liver lung cancer lymphoma malignant melanoma melphalan metastatic methotrexate mg per m² mg/m² mitomycin neck cancer Oncology Group ovarian overall survival oxaliplatin paclitaxel patients receiving patients treated perfusion pharmacokinetic phase II study phase II trial pregnancy procarbazine pulmonary radiotherapy randomized trial reactions recurrent regimen renal reported response rate risk stem cell syndrome systemic testicular tissue toxicity trastuzumab treatment tumor venous versus vinblastine vincristine vinorelbine